• Science & Technology

Paving the way: How biopsies are offering hope to children with aggressive brain tumours

7 March 2022

• Science & Technology
• For Researchers

Disease in a dish: Mini-gut organoids and the challenges of bowel cancer

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

11 February 2022

• Health & Medicine

Aromatase inhibitors cut breast cancer recurrence in younger patients

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

11 February 2022

• Health & Medicine
• Science & Technology

Diving into our role in 50 top cancer drugs

To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today. To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today.

9 February 2022

• Policy & Insight

Opinion: “We’ve been pushing for change for 20 years. We’re not stopping now”

This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve. This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve.

24 January 2022

• Science & Technology
• For Researchers

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

24 January 2022

• For Researchers

A new year of expanding research horizons

Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come

21 January 2022

• Science & Technology
• Health & Medicine

Prising open the trap: Getting to grips with targeted cancer drug resistance

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

10 January 2022

• For Researchers

It’s a fair COP: Why our chief clinician went to a climate change summit

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

13 December 2021

• For Researchers

How could proposed changes to data protection laws affect research?

As the Government sets out proposals to reform data protection laws, what could this mean for researchers? As the Government sets out proposals to reform data protection laws, what could this mean for researchers?

8 December 2021